PRIA Logo™
New YorkA 90102025-2026 Regular SessionHouse

Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic

Sponsored By: Linda Rosenthal (Democratic)

In Committee

Health

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Linda Rosenthal

    Democratic • House

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. PRINT NUMBER 9010B

    5/4/2026House

  2. AMEND AND RECOMMIT TO HEALTH

    5/4/2026House

  3. PRINT NUMBER 9010A

    1/22/2026House

  4. AMEND AND RECOMMIT TO HEALTH

    1/22/2026House

  5. REFERRED TO HEALTH

    1/7/2026House

  6. REFERRED TO HEALTH

    8/13/2025House

Bill Text

  • Original

    8/13/2025

    PDF

Related Bills

Back to State Legislation